X-chromosome inactivation draws L1 mutagenesis to the human X chromosome.Authors: de Los Rios Barreda J, Ferreiro ME, Jansz N, Bell CC, Botto JM, Nguyen TV, Pradhan B, Chen M, Colomer-Boronat A, Da Costa Guevara DJ, Flasch DA, Gericke S, Wilson TE, Ewing AD, Heras SR, Sanchez-Luque FJ, Lister R, Moran JV, Faulkner GJ07/2026 - Science (New York, N.Y.)
In vivo delivery strategies for therapeutic CRISPR genome editing.Authors: Martin L, Bohinc J, Recchia A, Gritti S, Santilli G, Zeyland J, Vidaković M, Grdović N, Benabdellah K, Ortiz-Bueno M, Butuner BD, Pisaniello L, Stilhano R, Benati D, Hapil FZ, Khawaja S, Nair RR, Giacomelli C, Atilla E, Zinghirino F, Ferrari T, Corradi F, Laufer TJ, Khnykin D, Aseguinolaza GG, Skrbinek M, Mlakar T, Lapanja T, Lainšček D07/2026 - International journal of biological sciences
Aligning preclinical AML models with immunotherapy development: principles for model selection.Authors: Karaca E, Atilla PA, Green DJ, Atilla E07/2026 - Frontiers in immunology
